Breaking News Instant updates and real-time market news.

USB

U.S. Bancorp

$53.30

0.13 (0.24%)

04:55
08/20/18
08/20
04:55
08/20/18
04:55

U.S. Bancorp management to meet with RBC Capital

Meeting to be held in Boston on August 20 hosted by RBC Capital.

  • 20

    Aug

USB U.S. Bancorp
$53.30

0.13 (0.24%)

05/11/18
SBSH
05/11/18
UPGRADE
Target $58
SBSH
Buy
Citi upgrades U.S. Bancorp, says opportune time to build positions
Citi analyst Keith Horowitz upgraded U.S. Bancorp to Buy from Neutral with an unchanged price target of $58. Now is an opportune time to build positions in the stock after three years of significant underperformance, Horowitz tells investors in a research note. He believes the drivers of the underperformance have largely played out and that U.S. Bancorp's efficiency ratio will improve from here. Further, the bank's "strong" credit quality profile can be a differentiator as the cycle gets into the latter innings, Horowitz contends. He says U.S. Bancorp is one of the best ways for investors looking to add exposure to the banks.
05/11/18
05/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Overweight from Neutral at JPMorgan with analyst Philip Cusick saying after a meeting with CEO Lowell McAdam, he has a better understanding that Verizon's "organic approach to wireless has the company on an increasingly stable footing." 2. Mosaic (MOS) upgraded to Outperform from Sector Perform at RBC Capital with analyst Andrew Wong saying that it is "hard to ignore the improving undercurrents in both phosphate and potash markets." 3. Ultragenyx (RARE) upgraded to Overweight from Equal Weight at Barclays with analyst Gena Wang saying she thinks a higher price target for Crysvita could drive upside to revenue growth expectations. 4. U.S. Bancorp (USB) upgraded to Buy from Neutral at Citi with analyst Keith Horowitz saying now is an opportune time to build positions in the stock after three years of significant underperformance. 5. AMC Networks (AMCX) upgraded to Buy from Hold at Gabelli with the firm saying it remains an excelling company with opportunities to leverage its recent programming momentum into increased advertising and affiliate fees. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.
07/18/18
SPHN
07/18/18
NO CHANGE
Target $105
SPHN
Overweight
Comerica could be viewed as acquisition target, says Stephens
Stephens analyst Terry McEvoy raised his capital payout forecast for Comerica (CMA) for the second half of this year and for 2019 as he expects the company will announce an increase in the dividend and larger buyback plan after its board meets on July 24. Additionally, McEvoy thinks Comerica could be viewed as an takeover target once BB&T (BBT) and U.S. Bancorp (USB) are in a position to acquire banks. Stating that he likes both its fundamental and strategic outlook, McEvoy keeps an Overweight rating and $105 price target on Comerica shares.

TODAY'S FREE FLY STORIES

SABR

Sabre

$22.80

0.36 (1.60%)

05:44
06/19/19
06/19
05:44
06/19/19
05:44
Downgrade
Sabre rating change  »

Goldman downgrades Sabre…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMRF

ABN Amro

$0.00

(0.00%)

05:41
06/19/19
06/19
05:41
06/19/19
05:41
Upgrade
ABN Amro rating change  »

ABN Amro upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASMIY

ASMI

$0.00

(0.00%)

05:38
06/19/19
06/19
05:38
06/19/19
05:38
Initiation
ASMI initiated  »

ASMI initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STM

STMicroelectronics

$16.10

0.505 (3.24%)

05:37
06/19/19
06/19
05:37
06/19/19
05:37
Initiation
STMicroelectronics initiated  »

STMicroelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASML

ASML

$194.67

5.12 (2.70%)

05:37
06/19/19
06/19
05:37
06/19/19
05:37
Initiation
ASML initiated  »

ASML initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

ALK

Alaska Air

$62.90

0.39 (0.62%)

05:18
06/19/19
06/19
05:18
06/19/19
05:18
Recommendations
Alaska Air analyst commentary  »

Alaska Air price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQV

Iqvia

$145.74

4.335 (3.07%)

05:16
06/19/19
06/19
05:16
06/19/19
05:16
Recommendations
Iqvia analyst commentary  »

Iqvia share reaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

AIMT

Aimmune

$20.20

-0.33 (-1.61%)

05:14
06/19/19
06/19
05:14
06/19/19
05:14
Recommendations
Aimmune analyst commentary  »

Piper views setup for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

TBPH

Theravance Biopharma

$16.61

-0.1 (-0.60%)

05:11
06/19/19
06/19
05:11
06/19/19
05:11
Recommendations
Theravance Biopharma analyst commentary  »

Piper reiterates $55…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SABR

Sabre

$22.80

0.36 (1.60%)

05:06
06/19/19
06/19
05:06
06/19/19
05:06
Downgrade
Sabre rating change  »

Sabre downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LW

Lamb Weston

$58.97

-0.88 (-1.47%)

05:05
06/19/19
06/19
05:05
06/19/19
05:05
Upgrade
Lamb Weston rating change  »

Lamb Weston upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$10.16

1.89 (22.85%)

05:04
06/19/19
06/19
05:04
06/19/19
05:04
Downgrade
SunPower rating change  »

SunPower downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAGY

IAG

$0.00

(0.00%)

05:03
06/19/19
06/19
05:03
06/19/19
05:03
Downgrade
IAG rating change  »

IAG downgraded to Reduce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESYJY

easyJet

$0.00

(0.00%)

05:02
06/19/19
06/19
05:02
06/19/19
05:02
Downgrade
easyJet rating change  »

easyJet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFLYY

Air France-KLM

$0.00

(0.00%)

05:01
06/19/19
06/19
05:01
06/19/19
05:01
Downgrade
Air France-KLM rating change  »

Air France-KLM downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$102.20

1.8 (1.79%)

05:00
06/19/19
06/19
05:00
06/19/19
05:00
Downgrade
Mirati Therapeutics rating change  »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFNNY

Infineon

$0.00

(0.00%)

04:57
06/19/19
06/19
04:57
06/19/19
04:57
Initiation
Infineon initiated  »

Infineon initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

04:56
06/19/19
06/19
04:56
06/19/19
04:56
Downgrade
Energizer rating change  »

Energizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JSTTY

Just Eat

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Downgrade
Just Eat rating change  »

Just Eat downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
06/19/19
06/19
04:55
06/19/19
04:55
General news
Breaking General news story  »

FOMC Forecasts to be…

WMT

Walmart

$109.66

0.51 (0.47%)

, IPAR

Inter Parfums

$66.80

0.51 (0.77%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Jefferies to hold a conference »

2019 Global Consumer…

WMT

Walmart

$109.66

0.51 (0.47%)

IPAR

Inter Parfums

$66.80

0.51 (0.77%)

PG

Procter & Gamble

$109.60

-1.385 (-1.25%)

VGR

Vector Group

$9.61

-0.21 (-2.14%)

CHDN

Churchill Downs

$115.82

1.71 (1.50%)

CLUB

Town Sports

$2.41

-0.09 (-3.60%)

IGT

International Game

$13.62

0.5 (3.81%)

TACO

Del Taco

$11.44

0.11 (0.97%)

WYND

Wyndham Destinations

$42.93

0.18 (0.42%)

VAC

Marriott Vacations

$98.69

1.46 (1.50%)

KIM

Kimco Realty

$18.99

-0.02 (-0.11%)

AEO

American Eagle

$17.69

-0.27 (-1.50%)

LOCO

El Pollo Loco

$10.94

-0.11 (-1.00%)

BJ

BJ's Wholesale

$25.09

0.3 (1.21%)

TCX

Tucows

$61.30

-0.01 (-0.02%)

COT

Cott Corp.

$13.88

0.02 (0.14%)

CRMT

America's Car-Mart

$84.97

-1.62 (-1.87%)

DG

Dollar General

$137.03

1.18 (0.87%)

NUS

Nu Skin

$50.47

0.815 (1.64%)

CHEF

Chefs' Warehouse

$33.84

0.11 (0.33%)

HLF

Herbalife Nutrition

$43.87

0.83 (1.93%)

OLLI

Ollie's Bargain Outlet

$92.00

-0.32 (-0.35%)

SPTN

SpartanNash

$11.42

0.1 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 25

    Jul

  • 15

    Aug

  • 13

    Nov

GFN

General Finance Corp

$8.19

0.27 (3.41%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
General Finance Corp management to meet with Craig-Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

SEEL

Seelos Therapeutics

$2.26

0.075 (3.44%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Seelos Therapeutics management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

IBTX

Independent Bank

$54.77

1.26 (2.35%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Independent Bank management to meet with Sandler ONeill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 26

    Aug

SMG

Scotts Miracle-Gro

$98.13

1.24 (1.28%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Scotts Miracle-Gro management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 21

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.